APO RESEARCH · REPORT
COVID-19 Antibody Detection Kits
COVID-19 testing can identify the SARS-CoV-2 virus and includes methods that detect the presence of virus itself (RT-PCR and isothermal nucleic acid amplification) and those that detect antibodies produced in response to infection. Detection of antibodies (serology) can be used both for diagnosis and population surveillance. Antibody tests show how many people have had the disease, including those whose symptoms were minor or who were asymptomatic. An accurate mortality rate of the disease and the level of herd immunity in the population can be determined from the results of this test. However, the duration and effectiveness of this immune response are still unclear.
Product & engineering
Understand the product.
COVID-19 testing can identify the SARS-CoV-2 virus and includes methods that detect the presence of virus itself (RT-PCR and isothermal nucleic acid amplification) and those that detect antibodies produced in response to infection. Detection of antibodies (serology) can be used both for diagnosis and population surveillance. Antibody tests show how many people have had the disease, including those whose symptoms were minor or who were asymptomatic. An accurate mortality rate of the disease and the level of herd immunity in the population can be determined from the results of this test. However, the duration and effectiveness of this immune response are still unclear.
Selected research
Industry Research
COVID-19 Antibody Detection Kits Industry Research Report 2026
Market perspective
COVID-19 testing can identify the SARS-CoV-2 virus and includes methods that detect the presence of virus itself (RT-PCR and isothermal nucleic acid amplification) and those that detect antibodies produced in response to infection. Detection of antibodies (serology) can be used both for diagnosis and population surveillance. Antibody tests show how many people have had the disease, including those whose symptoms were minor or who were asymptomatic. An accurate mortality rate of the disease and the level of herd immunity in the population can be determined from the results of this test. However, the duration and effectiveness of this immune response are still unclear.
In the last several months, global consumption market of COVID-19 Antibody Detection Kits industry developed with the average growth rate of 303% during last two months. In 2020, global consumption of COVID-19 Antibody Detection Kits reached 2838 K Unit on April. At the same time, global consumption of COVID-19 Antibody Detection Kits reached 24.64 M Unit on April.
According to our prediction, Europe is the largest consumer of COVID-19 Antibody Detection Kits in global market.The second place is North America, following Europe.
Read the full market overview
Report Scope
This report quantifies the global COVID-19 Antibody Detection Kits market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
COVID-19 Antibody Detection Kits Market by Company
Cellex
Abbott
Roche
BioMedomics
BD
Henry Schein
Safecare Bio-Tech
Mayo Clinic Laboratories
Chembio Diagnostics
Mount Sinai Laboratory
Ortho Clinical Diagnostics
Zhejiang Orient Gene Biotech
Innovita Biological Technology
Guangzhou Wondfo Biotech
Guangdong Hecin-Scientific
Dynamiker Biotechnology (Tianjin)
ADVAITE
COVID-19 Antibody Detection Kits Segment by Type
Rapid Diagnostic Test (RDT)
Enzyme Linked Immunosorbent Assay (ELISA)
Neutralization Assay
COVID-19 Antibody Detection Kits Segment by Application
Hospitals
Scientific Research
COVID-19 Antibody Detection Kits Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global COVID-19 Antibody Detection Kits market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of COVID-19 Antibody Detection Kits and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of COVID-19 Antibody Detection Kits.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of COVID-19 Antibody Detection Kits manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of COVID-19 Antibody Detection Kits by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of COVID-19 Antibody Detection Kits in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Rapid Diagnostic Test (RDT)
- Enzyme Linked Immunosorbent Assay (ELISA)
- Neutralization Assay
Applications
- Hospitals
- Scientific Research
Companies covered
- Cellex
- Abbott
- Roche
- BioMedomics
- BD
- Henry Schein
- Safecare Bio-Tech
- Mayo Clinic Laboratories
- Chembio Diagnostics
- Mount Sinai Laboratory
- Ortho Clinical Diagnostics
- Zhejiang Orient Gene Biotech
- Innovita Biological Technology
- Guangzhou Wondfo Biotech
- Guangdong Hecin-Scientific
- Dynamiker Biotechnology (Tianjin)
- ADVAITE
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global COVID-19 Antibody Detection Kits Market Size (2021-2032)
- 2.2.2 Global COVID-19 Antibody Detection Kits Sales (2021-2032)
- 2.2.3 Global COVID-19 Antibody Detection Kits Market Average Price (2021-2032)
- 2.3 COVID-19 Antibody Detection Kits by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Rapid Diagnostic Test (RDT)
- 2.3.3 Enzyme Linked Immunosorbent Assay (ELISA)
- 2.3.4 Neutralization Assay
- 2.4 COVID-19 Antibody Detection Kits by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospitals
- 2.4.3 Scientific Research
3 Market Competitive Landscape by Manufacturers
- 3.1 Global COVID-19 Antibody Detection Kits Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global COVID-19 Antibody Detection Kits Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global COVID-19 Antibody Detection Kits Revenue of Manufacturers (2021-2026)
- 3.4 Global COVID-19 Antibody Detection Kits Average Price by Manufacturers (2021-2026)
- 3.5 Global COVID-19 Antibody Detection Kits Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of COVID-19 Antibody Detection Kits, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of COVID-19 Antibody Detection Kits, Product Type & Application
- 3.8 Global Manufacturers of COVID-19 Antibody Detection Kits, Established Date
- 3.9 Global COVID-19 Antibody Detection Kits Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Cellex
- 4.1.1 Cellex Company Information
- 4.1.2 Cellex Business Overview
- 4.1.3 Cellex COVID-19 Antibody Detection Kits Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Cellex COVID-19 Antibody Detection Kits Product Portfolio
- 4.1.5 Cellex Recent Developments
- 4.2 Abbott
- 4.2.1 Abbott Company Information
- 4.2.2 Abbott Business Overview
- 4.2.3 Abbott COVID-19 Antibody Detection Kits Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Abbott COVID-19 Antibody Detection Kits Product Portfolio
- 4.2.5 Abbott Recent Developments
- 4.3 Roche
- 4.3.1 Roche Company Information
- 4.3.2 Roche Business Overview
- 4.3.3 Roche COVID-19 Antibody Detection Kits Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Roche COVID-19 Antibody Detection Kits Product Portfolio
- 4.3.5 Roche Recent Developments
- 4.4 BioMedomics
- 4.4.1 BioMedomics Company Information
- 4.4.2 BioMedomics Business Overview
- 4.4.3 BioMedomics COVID-19 Antibody Detection Kits Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 BioMedomics COVID-19 Antibody Detection Kits Product Portfolio
- 4.4.5 BioMedomics Recent Developments
- 4.5 BD
- 4.5.1 BD Company Information
- 4.5.2 BD Business Overview
- 4.5.3 BD COVID-19 Antibody Detection Kits Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 BD COVID-19 Antibody Detection Kits Product Portfolio
- 4.5.5 BD Recent Developments
- 4.6 Henry Schein
- 4.6.1 Henry Schein Company Information
- 4.6.2 Henry Schein Business Overview
- 4.6.3 Henry Schein COVID-19 Antibody Detection Kits Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Henry Schein COVID-19 Antibody Detection Kits Product Portfolio
- 4.6.5 Henry Schein Recent Developments
- 4.7 Safecare Bio-Tech
- 4.7.1 Safecare Bio-Tech Company Information
- 4.7.2 Safecare Bio-Tech Business Overview
- 4.7.3 Safecare Bio-Tech COVID-19 Antibody Detection Kits Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Safecare Bio-Tech COVID-19 Antibody Detection Kits Product Portfolio
- 4.7.5 Safecare Bio-Tech Recent Developments
- 4.8 Mayo Clinic Laboratories
- 4.8.1 Mayo Clinic Laboratories Company Information
- 4.8.2 Mayo Clinic Laboratories Business Overview
- 4.8.3 Mayo Clinic Laboratories COVID-19 Antibody Detection Kits Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Mayo Clinic Laboratories COVID-19 Antibody Detection Kits Product Portfolio
- 4.8.5 Mayo Clinic Laboratories Recent Developments
- 4.9 Chembio Diagnostics
- 4.9.1 Chembio Diagnostics Company Information
- 4.9.2 Chembio Diagnostics Business Overview
- 4.9.3 Chembio Diagnostics COVID-19 Antibody Detection Kits Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Chembio Diagnostics COVID-19 Antibody Detection Kits Product Portfolio
- 4.9.5 Chembio Diagnostics Recent Developments
- 4.10 Mount Sinai Laboratory
- 4.10.1 Mount Sinai Laboratory Company Information
- 4.10.2 Mount Sinai Laboratory Business Overview
- 4.10.3 Mount Sinai Laboratory COVID-19 Antibody Detection Kits Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Mount Sinai Laboratory COVID-19 Antibody Detection Kits Product Portfolio
- 4.10.5 Mount Sinai Laboratory Recent Developments
- 4.11 Ortho Clinical Diagnostics
- 4.11.1 Ortho Clinical Diagnostics Company Information
- 4.11.2 Ortho Clinical Diagnostics Business Overview
- 4.11.3 Ortho Clinical Diagnostics COVID-19 Antibody Detection Kits Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Ortho Clinical Diagnostics COVID-19 Antibody Detection Kits Product Portfolio
- 4.11.5 Ortho Clinical Diagnostics Recent Developments
- 4.12 Zhejiang Orient Gene Biotech
- 4.12.1 Zhejiang Orient Gene Biotech Company Information
- 4.12.2 Zhejiang Orient Gene Biotech Business Overview
- 4.12.3 Zhejiang Orient Gene Biotech COVID-19 Antibody Detection Kits Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Zhejiang Orient Gene Biotech COVID-19 Antibody Detection Kits Product Portfolio
- 4.12.5 Zhejiang Orient Gene Biotech Recent Developments
- 4.13 Innovita Biological Technology
- 4.13.1 Innovita Biological Technology Company Information
- 4.13.2 Innovita Biological Technology Business Overview
- 4.13.3 Innovita Biological Technology COVID-19 Antibody Detection Kits Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Innovita Biological Technology COVID-19 Antibody Detection Kits Product Portfolio
- 4.13.5 Innovita Biological Technology Recent Developments
- 4.14 Guangzhou Wondfo Biotech
- 4.14.1 Guangzhou Wondfo Biotech Company Information
- 4.14.2 Guangzhou Wondfo Biotech Business Overview
- 4.14.3 Guangzhou Wondfo Biotech COVID-19 Antibody Detection Kits Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Guangzhou Wondfo Biotech COVID-19 Antibody Detection Kits Product Portfolio
- 4.14.5 Guangzhou Wondfo Biotech Recent Developments
- 4.15 Guangdong Hecin-Scientific
- 4.15.1 Guangdong Hecin-Scientific Company Information
- 4.15.2 Guangdong Hecin-Scientific Business Overview
- 4.15.3 Guangdong Hecin-Scientific COVID-19 Antibody Detection Kits Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Guangdong Hecin-Scientific COVID-19 Antibody Detection Kits Product Portfolio
- 4.15.5 Guangdong Hecin-Scientific Recent Developments
- 4.16 Dynamiker Biotechnology (Tianjin)
- 4.16.1 Dynamiker Biotechnology (Tianjin) Company Information
- 4.16.2 Dynamiker Biotechnology (Tianjin) Business Overview
- 4.16.3 Dynamiker Biotechnology (Tianjin) COVID-19 Antibody Detection Kits Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Dynamiker Biotechnology (Tianjin) COVID-19 Antibody Detection Kits Product Portfolio
- 4.16.5 Dynamiker Biotechnology (Tianjin) Recent Developments
- 4.17 ADVAITE
- 4.17.1 ADVAITE Company Information
- 4.17.2 ADVAITE Business Overview
- 4.17.3 ADVAITE COVID-19 Antibody Detection Kits Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 ADVAITE COVID-19 Antibody Detection Kits Product Portfolio
- 4.17.5 ADVAITE Recent Developments
5 Global COVID-19 Antibody Detection Kits Market Scenario by Region
- 5.1 Global COVID-19 Antibody Detection Kits Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global COVID-19 Antibody Detection Kits Sales by Region: 2021-2032
- 5.2.1 Global COVID-19 Antibody Detection Kits Sales by Region: 2021-2026
- 5.2.2 Global COVID-19 Antibody Detection Kits Sales by Region: 2027-2032
- 5.3 Global COVID-19 Antibody Detection Kits Revenue by Region: 2021-2032
- 5.3.1 Global COVID-19 Antibody Detection Kits Revenue by Region: 2021-2026
- 5.3.2 Global COVID-19 Antibody Detection Kits Revenue by Region: 2027-2032
- 5.4 North America COVID-19 Antibody Detection Kits Market Facts & Figures by Country
- 5.4.1 North America COVID-19 Antibody Detection Kits Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America COVID-19 Antibody Detection Kits Sales by Country (2021-2032)
- 5.4.3 North America COVID-19 Antibody Detection Kits Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe COVID-19 Antibody Detection Kits Market Facts & Figures by Country
- 5.5.1 Europe COVID-19 Antibody Detection Kits Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe COVID-19 Antibody Detection Kits Sales by Country (2021-2032)
- 5.5.3 Europe COVID-19 Antibody Detection Kits Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific COVID-19 Antibody Detection Kits Market Facts & Figures by Country
- 5.6.1 Asia Pacific COVID-19 Antibody Detection Kits Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific COVID-19 Antibody Detection Kits Sales by Country (2021-2032)
- 5.6.3 Asia Pacific COVID-19 Antibody Detection Kits Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America COVID-19 Antibody Detection Kits Market Facts & Figures by Country
- 5.7.1 South America COVID-19 Antibody Detection Kits Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America COVID-19 Antibody Detection Kits Sales by Country (2021-2032)
- 5.7.3 South America COVID-19 Antibody Detection Kits Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa COVID-19 Antibody Detection Kits Market Facts & Figures by Country
- 5.8.1 Middle East and Africa COVID-19 Antibody Detection Kits Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa COVID-19 Antibody Detection Kits Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa COVID-19 Antibody Detection Kits Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global COVID-19 Antibody Detection Kits Sales by Type (2021-2032)
- 6.1.1 Global COVID-19 Antibody Detection Kits Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global COVID-19 Antibody Detection Kits Sales Market Share by Type (2021-2032)
- 6.2 Global COVID-19 Antibody Detection Kits Revenue by Type (2021-2032)
- 6.2.1 Global COVID-19 Antibody Detection Kits Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global COVID-19 Antibody Detection Kits Revenue Market Share by Type (2021-2032)
- 6.3 Global COVID-19 Antibody Detection Kits Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global COVID-19 Antibody Detection Kits Sales by Application (2021-2032)
- 7.1.1 Global COVID-19 Antibody Detection Kits Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global COVID-19 Antibody Detection Kits Sales Market Share by Application (2021-2032)
- 7.2 Global COVID-19 Antibody Detection Kits Revenue by Application (2021-2032)
- 7.2.1 Global COVID-19 Antibody Detection Kits Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global COVID-19 Antibody Detection Kits Revenue Market Share by Application (2021-2032)
- 7.3 Global COVID-19 Antibody Detection Kits Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 COVID-19 Antibody Detection Kits Value Chain Analysis
- 8.1.1 COVID-19 Antibody Detection Kits Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 COVID-19 Antibody Detection Kits Production Mode & Process
- 8.2 COVID-19 Antibody Detection Kits Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 COVID-19 Antibody Detection Kits Distributors
- 8.2.3 COVID-19 Antibody Detection Kits Customers
9 Global COVID-19 Antibody Detection Kits Analyzing Market Dynamics
- 9.1 COVID-19 Antibody Detection Kits Industry Trends
- 9.2 COVID-19 Antibody Detection Kits Industry Drivers
- 9.3 COVID-19 Antibody Detection Kits Industry Opportunities and Challenges
- 9.4 COVID-19 Antibody Detection Kits Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst